ABIVAX Société Anonyme

EPA:ABVX.PA

9.61 (EUR) • At close November 8, 2024
Bedrijfsnaam ABIVAX Société Anonyme
Symbool ABVX.PA
Munteenheid EUR
Prijs 9.61
Beurswaarde 608,152,215
Dividendpercentage 0%
52-weken bereik 8.12 - 15.42
Industrie Biotechnology
Sector Healthcare
CEO Mr. Marc M. P. de Garidel M.B.A.
Website https://www.abivax.com

An error occurred while fetching data.

Over ABIVAX Société Anonyme

ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for

Vergelijkbare Aandelen

Guerbet SA logo

Guerbet SA

GBT.PA

29.85 EUR

Bastide Le Confort Médical SA logo

Bastide Le Confort Médical SA

BLC.PA

17.84 EUR

Mithra Pharmaceuticals SA logo

Mithra Pharmaceuticals SA

MITRA.BR

0.216 EUR

Prim, S.A. logo

Prim, S.A.

PRM.MC

9.74 EUR

Cegedim SA logo

Cegedim SA

CGM.PA

11.45 EUR

Laboratorio Reig Jofre, S.A. logo

Laboratorio Reig Jofre, S.A.

RJF.MC

2.92 EUR

Eurobio Scientific Société anonyme logo

Eurobio Scientific Société anonyme

ALERS.PA

25.75 EUR

Transgene SA logo

Transgene SA

TNG.PA

0.871 EUR

Carmat SA logo

Carmat SA

ALCAR.PA

1.354 EUR

Innate Pharma S.A. logo

Innate Pharma S.A.

IPH.PA

1.61 EUR

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)